Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
CRANBURY, N.J., Feb. 16 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced results for its second quarter ended December 31, 2009. Palatin reported net income...
CRANBURY, N.J., Feb. 9 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of...
CRANBURY, N.J., Dec. 1 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,622,440...
CRANBURY, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced results for its quarter ended September 30, 2009. Palatin reported a net loss of...
CRANBURY, N.J., Nov. 12 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) will announce its first quarter, fiscal year 2010 financial results on Monday, November 16, 2009...
CRANBURY, N.J., Oct. 28 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) announced that it will be presenting at the 2009 BIO Investor Forum on Thursday, October 29, 2009 at...
CRANBURY, N.J., Sept. 29 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) today announced that it will receive $5 million from AstraZeneca relating to an amendment of its...
CRANBURY, N.J., Sept. 15 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) announced that a poster on clinical trial results with PL-3994, its product for heart failure, will...
Palatin Technologies, Inc. (NYSE Amex: PTN) today announced results for its fourth quarter and fiscal year ended June 30, 2009. For the year ended June 30, 2009, total revenues were $11.4...
CRANBURY, N.J., Sept. 4 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (NYSE Amex: PTN) will announce its fourth quarter and fiscal year 2009 financial results on Tuesday, September 8...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.103 | -10.0194552529 | 1.028 | 1.078 | 0.841 | 22130 | 0.91102828 | DE |
| 4 | -0.109 | -10.5415860735 | 1.034 | 1.38 | 0.841 | 23479 | 1.06890997 | DE |
| 12 | -0.521 | -36.030428769 | 1.446 | 1.532 | 0.64 | 15627 | 0.98922736 | DE |
| 26 | -1.019 | -52.4176954733 | 1.944 | 1.944 | 0.64 | 9633 | 1.11046663 | DE |
| 52 | -0.885 | -48.8950276243 | 1.81 | 5.15 | 0.64 | 10615 | 1.77848422 | DE |
| 156 | -0.955 | -50.7978723404 | 1.88 | 5.15 | 0.64 | 9496 | 1.77692722 | DE |
| 260 | -0.955 | -50.7978723404 | 1.88 | 5.15 | 0.64 | 9496 | 1.77692722 | DE |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
